Akili, the company behind video game-like prescription and over-the-counter digital therapeutics for individuals with ADHD, has signed a definitive merger agreement with mental health and fitness company Virtual Therapeutics in a deal reportedly worth $34 million.
Under the agreement, which is slated to close in the third quarter of 2024, Akili shareholders will receive $0.4340 per share of...
